Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder

NCT05529927 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

204

Enrollment

OTHER

Sponsor class

Conditions

Cocaine Use Disorder

Interventions

DRUG: Sustained-release Dexamphetamine
DRUG: Placebo

Sponsor

Parnassia Addiction Research Centre

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]